Concepedia

Author

Katie Flaherty

University of NottinghamORCID

Also Known As

K Flaherty, Katie Flaherty, Katie R. Flaherty, Katsoulis, L., on behalf of the TICH-2 investigators

32

Publications

893

Citations

11

H-Index

11

Concepts

All Affiliations

University of NottinghamNottingham University Hospitals NHS TrustUniversity of EdinburghUniversity of LeicesterNational University of Malaysia
KF

About

Katie Flaherty is an author at University of Nottingham specializing in pharmacotherapy, cerebrovascular disease, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

49

2

Public Health

1

1

49

3

Neurology

1

1

49

4

Pharmacology

1

1

49

5

Ischemic Stroke

1

1

49

Katie Flaherty

×

9

Publications

803

Citations

9

H-Index

YearCitations

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Nikola Sprigg, Katie Flaherty, Jason P. Appleton,

The Lancet

2018

462

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton,

The Lancet

2017

176

Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial

Gordon W. Blair, Jason P. Appleton, Katie Flaherty,

EClinicalMedicine

2019

49

Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

Nikola Sprigg, Katie Flaherty, Jason P. Appleton,

Health Technology Assessment

2019

28

Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign

Christian Ovesen, Janus Christian Jakobsen, Christian Gluud,

Stroke

2021

25

Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination

Gordon W. Blair, Jason P. Appleton, Zhe Kang Law,

International Journal of Stroke

2017

24

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton,

Health Technology Assessment

2018

15

Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack

Philip M. Bath, Jane May, Katie Flaherty,

Stroke Research and Treatment

2017

13

Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial

Jason P. Appleton, Gordon W. Blair, Katie Flaherty,

Frontiers in Neurology

2019

11

Page 1